Literature DB >> 33435197

Herpesvirus Antibodies, Vitamin D and Short-Chain Fatty Acids: Their Correlation with Cell Subsets in Multiple Sclerosis Patients and Healthy Controls.

Maria Inmaculada Dominguez-Mozo1, Silvia Perez-Perez1, Noelia Villarrubia2, Lucienne Costa-Frossard3, Jose Ignacio Fernandez-Velasco2, Isabel Ortega-Madueño1, Maria Angel Garcia-Martinez1, Estefania Garcia-Calvo4, Hector Estevez4, Jose Luis Luque Garcia4, Maria Josefa Torrejon5, Rafael Arroyo6, Luisa Maria Villar2, Roberto Alvarez-Lafuente1.   

Abstract

Although the etiology of multiple sclerosis (MS) is still unknown, it is commonly accepted that environmental factors could contribute to the disease. The objective of this study was to analyze the humoral response to Epstein-Barr virus, human herpesvirus 6A/B and cytomegalovirus, and the levels of 25-hydroxyvitamin D (25(OH)D) and the three main short-chain fatty acids (SCFA), propionate (PA), butyrate (BA) and acetate (AA), in MS patients and healthy controls (HC) to understand how they could contribute to the pathogenesis of the disease. With this purpose, we analyzed the correlations among them and with different clinical variables and a wide panel of cell subsets. We found statistically significant differences for most of the environmental factors analyzed when we compared MS patients and HC, supporting their possible involvement in the disease. The strongest correlations with the clinical variables and the cell subsets analyzed were found for 25(OH)D and SCFAs levels. A correlation was also found between 25(OH)D and PA/AA ratio, and the interaction between these factors negatively correlated with interleukin 17 (IL-17)-producing CD4+ and CD8+ T cells in untreated MS patients. Therapies that simultaneously increase vitamin D levels and modify the proportion of SCFA could be evaluated in the future.

Entities:  

Keywords:  ELISA; flow-cytometry; human herpesvirus; multiple sclerosis; vitamin D

Year:  2021        PMID: 33435197      PMCID: PMC7826528          DOI: 10.3390/cells10010119

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  70 in total

1.  Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis.

Authors:  Jan D Lünemann; Mar Tintoré; Brady Messmer; Till Strowig; Alex Rovira; Héctor Perkal; Estrella Caballero; Christian Münz; Xavier Montalban; Manuel Comabella
Journal:  Ann Neurol       Date:  2010-02       Impact factor: 10.422

2.  Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination.

Authors:  Naila Makhani; Brenda Banwell; Raymond Tellier; Carmen Yea; Suzanne McGovern; Julia O'Mahony; Jean M Ahorro; Douglas Arnold; A Dessa Sadovnick; Ruth A Marrie; Amit Bar-Or
Journal:  Mult Scler       Date:  2015-07-21       Impact factor: 6.312

3.  Vitamin D deficiency is associated with disability and disease progression in multiple sclerosis patients independently of oxidative and nitrosative stress.

Authors:  Sayonara R Oliveira; Andréa N C Simão; Daniela Frizon Alfieri; Tamires Flauzino; Ana Paula Kallaur; Leda Mezzaroba; Marcell Alysson B Lozovoy; Beatriz Sardinha Sabino; Katerine Panichi Zanin Ferreira; Wildea L C J Pereira; Damacio R Kaimen-Maciel; Isaias Dichi; Edna M V Reiche
Journal:  J Neurol Sci       Date:  2017-07-31       Impact factor: 3.181

4.  Bone metabolism and vitamin D status in patients with multiple sclerosis.

Authors:  Katarzyna Kępczyńska; Małgorzata Zajda; Zbigniew Lewandowski; Jerzy Przedlacki; Beata Zakrzewska-Pniewska
Journal:  Neurol Neurochir Pol       Date:  2016-04-27       Impact factor: 1.621

5.  Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.

Authors:  Raquel Alenda; Lucienne Costa-Frossard; Roberto Alvarez-Lafuente; Carmen Espejo; Eulalia Rodríguez-Martín; Susana Sainz de la Maza; Noelia Villarrubia; Jordi Río; María I Domínguez-Mozo; Xavier Montalban; José C Álvarez-Cermeño; Luisa M Villar
Journal:  J Neurol       Date:  2017-10-12       Impact factor: 4.849

6.  Adaptive Features of Natural Killer Cells in Multiple Sclerosis.

Authors:  Antía Moreira; Elisenda Alari-Pahissa; Elvira Munteis; Andrea Vera; Ana Zabalza; Mireia Llop; Noelia Villarrubia; Marcel Costa-García; Roberto Álvarez-Lafuente; Luisa María Villar; Miguel López-Botet; Jose E Martínez-Rodríguez
Journal:  Front Immunol       Date:  2019-10-15       Impact factor: 7.561

7.  Alterations in Circulating Fatty Acid Are Associated With Gut Microbiota Dysbiosis and Inflammation in Multiple Sclerosis.

Authors:  Marina Saresella; Ivana Marventano; Monica Barone; Francesca La Rosa; Federica Piancone; Laura Mendozzi; Alessia d'Arma; Valentina Rossi; Luigi Pugnetti; Gabriella Roda; Eleonora Casagni; Michele Dei Cas; Rita Paroni; Patrizia Brigidi; Silvia Turroni; Mario Clerici
Journal:  Front Immunol       Date:  2020-07-07       Impact factor: 7.561

Review 8.  Latitude, Vitamin D, Melatonin, and Gut Microbiota Act in Concert to Initiate Multiple Sclerosis: A New Mechanistic Pathway.

Authors:  Majid Ghareghani; Russel J Reiter; Kazem Zibara; Naser Farhadi
Journal:  Front Immunol       Date:  2018-10-30       Impact factor: 7.561

9.  Vitamin D and Disease Severity in Multiple Sclerosis-Baseline Data From the Randomized Controlled Trial (EVIDIMS).

Authors:  Priscilla Bäcker-Koduah; Judith Bellmann-Strobl; Michael Scheel; Jens Wuerfel; Klaus-Dieter Wernecke; Jan Dörr; Alexander Ulrich Brandt; Friedemann Paul
Journal:  Front Neurol       Date:  2020-02-25       Impact factor: 4.003

Review 10.  Why the elderly appear to be more severely affected by COVID-19: The potential role of immunosenescence and CMV.

Authors:  Seilesh Kadambari; Paul Klenerman; Andrew J Pollard
Journal:  Rev Med Virol       Date:  2020-07-15       Impact factor: 11.043

View more
  2 in total

Review 1.  Vitamin D as a Risk Factor for Multiple Sclerosis: Immunoregulatory or Neuroprotective?

Authors:  Sara E Gombash; Priscilla W Lee; Elizabeth Sawdai; Amy E Lovett-Racke
Journal:  Front Neurol       Date:  2022-05-16       Impact factor: 4.086

Review 2.  Gut microbiota dysbiosis: The potential mechanisms by which alcohol disrupts gut and brain functions.

Authors:  Ganggang Chen; Fenglei Shi; Wei Yin; Yao Guo; Anru Liu; Jiacheng Shuai; Jinhao Sun
Journal:  Front Microbiol       Date:  2022-07-29       Impact factor: 6.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.